Total Payments
$12,077
2024 Payments
$2,306
Companies
23
Transactions
159
Medicare Patients
6,877
Medicare Billing
$1.9M
Payment Breakdown by Category
Food & Beverage$6,136 (50.8%)
Other$5,000 (41.4%)
Travel$802.36 (6.6%)
Education$138.55 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,136 | 152 | 50.8% |
| Honoraria | $5,000 | 2 | 41.4% |
| Travel and Lodging | $802.36 | 2 | 6.6% |
| Education | $138.55 | 3 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alimera Sciences, Inc. | $5,225 | 11 | $0 (2024) |
| EyePoint Pharmaceuticals US, Inc. | $1,546 | 11 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $981.79 | 24 | $0 (2024) |
| Allergan, Inc. | $950.69 | 30 | $0 (2020) |
| Genentech USA, Inc. | $596.84 | 13 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $510.15 | 16 | $0 (2024) |
| ABBVIE INC. | $326.35 | 11 | $0 (2024) |
| Alcon Vision LLC | $287.63 | 4 | $0 (2024) |
| CooperVision Inc. | $214.49 | 2 | $0 (2023) |
| Mallinckrodt LLC | $192.10 | 9 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,306 | 33 | EyePoint Pharmaceuticals US, Inc. ($1,227) |
| 2023 | $1,147 | 31 | Regeneron Healthcare Solutions, Inc. ($286.57) |
| 2022 | $1,524 | 27 | Genentech USA, Inc. ($319.80) |
| 2021 | $355.35 | 11 | Regeneron Healthcare Solutions, Inc. ($195.45) |
| 2020 | $105.90 | 5 | Beaver-Visitec International, Inc. ($30.26) |
| 2019 | $5,417 | 15 | Alimera Sciences, Inc. ($5,081) |
| 2018 | $892.62 | 26 | Allergan Inc. ($590.96) |
| 2017 | $329.81 | 11 | Allergan Inc. ($155.02) |
All Payment Transactions
159 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: EYE CARE | ||||||
| 11/18/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $35.84 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/16/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Travel and Lodging | In-kind items and services | $401.18 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 11/16/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Travel and Lodging | In-kind items and services | $401.18 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 11/16/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Food and Beverage | In-kind items and services | $218.68 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 11/16/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Food and Beverage | In-kind items and services | $206.13 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 10/20/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $73.78 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/18/2024 | Carl Zeiss Meditec USA, Inc. | — | Food and Beverage | In-kind items and services | $153.81 | General |
| 10/18/2024 | Carl Zeiss Meditec USA, Inc. | — | Food and Beverage | In-kind items and services | $24.82 | General |
| 10/03/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $27.70 | General |
| Category: Ophthalmology | ||||||
| 10/03/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: EYE CARE | ||||||
| 09/26/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $38.37 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $26.10 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 08/29/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $32.45 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/26/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $7.01 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/22/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Ophthalmology | ||||||
| 08/14/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $31.87 | General |
| Category: Ophthalmology | ||||||
| 07/25/2024 | Harrow Eye, LLC | — | Food and Beverage | In-kind items and services | $14.18 | General |
| 07/24/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: IMMUNOLOGY | ||||||
| 07/16/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Education | In-kind items and services | $20.73 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/16/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Education | In-kind items and services | $19.83 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/12/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: IMMUNOLOGY | ||||||
| 06/11/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $30.58 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/31/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,739 | 5,000 | $922,834 | $460,494 |
| 2022 | 11 | 1,598 | 2,983 | $761,957 | $402,760 |
| 2021 | 9 | 1,744 | 3,620 | $920,588 | $519,677 |
| 2020 | 15 | 1,796 | 3,631 | $931,857 | $498,738 |
Total Patients
6,877
Total Services
15,234
Medicare Billing
$1.9M
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 41 | 292 | $306,600 | $199,601 | 65.1% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 659 | 968 | $133,584 | $88,221 | 66.0% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 11 | 1,740 | $69,600 | $50,552 | 72.6% |
| 67028 | Injection of drug into eye | Office | 2023 | 163 | 434 | $152,800 | $38,788 | 25.4% |
| 92134 | Imaging of retina | Office | 2023 | 663 | 1,163 | $116,300 | $33,386 | 28.7% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 116 | 308 | $27,720 | $16,331 | 58.9% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2023 | 16 | 22 | $77,000 | $15,489 | 20.1% |
| 67041 | Removal of membrane of retina | Facility | 2023 | 16 | 16 | $32,000 | $14,262 | 44.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 26 | 27 | $2,700 | $1,676 | 62.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 19 | $2,660 | $1,100 | 41.4% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 11 | 11 | $1,870 | $1,090 | 58.3% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 47 | 322 | $338,100 | $230,967 | 68.3% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 557 | 724 | $99,912 | $64,503 | 64.6% |
| 67028 | Injection of drug into eye | Office | 2022 | 157 | 428 | $142,200 | $37,841 | 26.6% |
| 92134 | Imaging of retina | Office | 2022 | 621 | 1,105 | $110,500 | $32,556 | 29.5% |
| 67041 | Removal of membrane of retina | Facility | 2022 | 17 | 17 | $34,000 | $15,798 | 46.5% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 112 | 295 | $26,550 | $15,307 | 57.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 32 | 35 | $3,500 | $2,274 | 65.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 19 | $2,660 | $1,617 | 60.8% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 12 | 12 | $2,040 | $1,162 | 56.9% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2022 | 12 | 14 | $2,015 | $511.72 | 25.4% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2022 | 12 | 12 | $480.00 | $224.21 | 46.7% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2021 | 55 | 418 | $438,900 | $308,156 | 70.2% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 638 | 1,049 | $144,722 | $97,947 | 67.7% |
| 67028 | Injection of drug into eye | Office | 2021 | 188 | 520 | $175,500 | $50,273 | 28.6% |
About Dr. Robert Coffee, MD
Dr. Robert Coffee, MD is a Retina Specialist healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558475582.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Coffee, MD has received a total of $12,077 in payments from pharmaceutical and medical device companies, with $2,306 received in 2024. These payments were reported across 159 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($6,136).
As a Medicare-enrolled provider, Coffee has provided services to 6,877 Medicare beneficiaries, totaling 15,234 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Retina Specialist
- Other Specialties Ophthalmology
- Location Houston, TX
- Active Since 08/18/2006
- Last Updated 11/27/2023
- Taxonomy Code 207WX0107X
- Entity Type Individual
- NPI Number 1558475582
Products in Payments
- Iluvien (Drug) $5,105
- EYP-1901 (Drug) $1,227
- OZURDEX (Drug) $1,040
- ACTHAR (Biological) $702.25
- EYLEA (Biological) $583.30
- EYLEA HD (Biological) $543.50
- YUTIQ (Drug) $276.69
- VABYSMO (Drug) $201.32
- Vabysmo (Drug) $182.14
- Constellation (Device) $146.54
- Izervay (Drug) $146.00
- MyDay Contact Lens (Device) $119.49
- SUSVIMO (Drug) $118.48
- VUITY (Drug) $98.23
- Multiple Brands Contact Lens (Device) $95.00
- DEXYCU (Drug) $90.27
- Stellaris (Device) $86.31
- Monaco (Device) $81.58
- EVA, combined machine (Device) $77.04
- Lucentis (Biological) $64.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Retina Specialist Doctors in Houston
Dr. Sami Dahr, Md, MD
Retina Specialist — Payments: $16,219
Retina Specialist $16,219
Petros Carvounis, M.d, M.D
Retina Specialist — Payments: $9,035
Retina Specialist $9,035
Dr. Keith Bourgeois, M.d, M.D
Retina Specialist — Payments: $7,131
Retina Specialist $7,131
Dr. Amir Mohsenin
Retina Specialist — Payments: $5,887
Retina Specialist $5,887
Dr. Charles Garcia, Md, MD
Retina Specialist — Payments: $3,753
Retina Specialist $3,753
Jaafar El Annan, M.d, M.D
Retina Specialist — Payments: $2,089
Retina Specialist $2,089